RPS6KA1 and ovarian carcinoma: We show that miR-634 regulates cyclin D1 and several Ras-MAPK pathway components (GRB2, ERK2, RSK1 and RSK2), which may contribute to the effects of miR-634 on ovarian cancer cell survival and chemotherapy response.